Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 45, 2011 - Issue 2
Submit an article Journal homepage
172
Views
8
CrossRef citations to date
0
Altmetric
Urology

Smarcc1 expression: A significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure

Rehne Lessman Hansen
,
Sara Heeboll Department of Urology; Department of Molecular Medicine
,
Peter David Ottosen Department of Pathology, Aarhus University Hospital, Denmark
,
Lars Dyrskjøt Department of Molecular Medicine
&
Michael Borre Department of UrologyCorrespondence[email protected]
Pages 91-96 | Received 24 Jul 2010, Accepted 28 Sep 2010, Published online: 18 Nov 2010

References

  • Eder IE, Bektic J, Haag P, Bartsch G, Klocker H. Genes differentially expressed in prostate cancer. BJU Int 2004;93:1151–5.
  • Torring N, Borre M, Sorensen KD, Andersen CL, Wiuf C, Orntoft TF. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. Br J Cancer 2007;96:499–506.
  • Heeboll S, Borre M, Ottosen PD, Andersen CL, Mansilla F, Dyrskjot L, Smarcc1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation. Histol Histopathol 2008;23:1069–76.
  • Ring HZ, Vameghi-Meyers V, Wang W, Crabtree GR, Francke U. Five SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin (SMARC) genes are dispersed in the human genome. Genomics 1998;51:140–3.
  • Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 2005;25:2200–15.
  • Roberts CW, Orkin SH. The SWI/SNF complex – chromatin and cancer. Nat Rev Cancer 2004;4:133–42.
  • Borre M, Nerstrom B, Overgaard J. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure. Cancer 1997;80:917–28.
  • Borre M, Bentzen SM, Nerstrom B, Overgaard J. Tumor cell proliferation and survival in patients with prostate cancer followed expectantly. J Urol 1998;159:1609–14.
  • Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844–7.
  • Harvei S, Tretli S, Langmark F. Quality of prostate cancer data in the cancer registry of Norway. Eur J Cancer 1996;32A:104–10.
  • Østerlind A, Jensen OM. Evaluering of cancerregistrering i Danmark 1977. Ugeskr Laeger 1985;31:2483–8.
  • Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312–9.
  • Kumar B, De Silva M, Venter DJ, Armes JE. Tissue microarrays: a practical guide. Pathology 2004;36:295–300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.